1. A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease. Issue 9 (23rd May 2016) Authors: Tison, François; Keywood, Charlotte; Wakefield, Mark; Durif, Franck; Corvol, Jean‐Christophe; Eggert, Karla; Lew, Mark; Isaacson, Stuart; Bezard, Erwan; Poli, Sonia‐Maria; Goetz, Christopher G.; Trenkwalder, Claudia; Rascol, Olivier Other Names: Sánchez‐Ferro Álvaro guestEditor.; Maetzler Walter guestEditor. Journal: Movement disorders Issue: Volume 31:Issue 9(2016) Page Start: 1373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acidic nanoparticles protect against α‐synuclein‐induced neurodegeneration through the restoration of lysosomal function. Issue 4 (23rd March 2022) Authors: Arotcarena, Marie‐Laure; Soria, Federico N.; Cunha, Anthony; Doudnikoff, Evelyne; Prévot, Geoffrey; Daniel, Jonathan; Blanchard‐Desce, Mireille; Barthélémy, Philippe; Bezard, Erwan; Crauste‐Manciet, Sylvie; Dehay, Benjamin Journal: Aging cell Issue: Volume 21:Issue 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alpha‐synuclein propagation: New insights from animal models. Issue 2 (8th September 2015) Authors: Dehay, Benjamin; Vila, Miquel; Bezard, Erwan; Brundin, Patrik; Kordower, Jeffrey H. Journal: Movement disorders Issue: Volume 31:Issue 2(2016) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice. Issue 5 (18th November 2016) Authors: Migdalska‐Richards, Anna; Daly, Liam; Bezard, Erwan; Schapira, Anthony H. V. Journal: Annals of neurology Issue: Volume 80:Issue 5(2016:Nov.) Page Start: 766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice. Issue 5 (November 2016) Authors: Migdalska‐Richards, Anna; Daly, Liam; Bezard, Erwan; Schapira, Anthony H. V. Journal: Annals of neurology Issue: Volume 80:Issue 5(2016:Nov.) Page Start: 766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-treated macaque models. (November 2016) Authors: Ko, Wai Kin D.; Camus, Sandrine M.; Li, Qin; Yang, Jianzhong; McGuire, Steve; Pioli, Elsa Y.; Bezard, Erwan Journal: Neuropharmacology Issue: Volume 110(2016) Part A Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in Primates. Issue 10 (14th September 2018) Authors: Charvin, Delphine; Di Paolo, Therese; Bezard, Erwan; Gregoire, Laurent; Takano, Akihiro; Duvey, Guillaume; Pioli, Elsa; Halldin, Christer; Medori, Rossella; Conquet, François Journal: Movement disorders Issue: Volume 33:Issue 10(2018) Page Start: 1619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies. Issue 1 (2nd July 2012) Authors: Bezard, Erwan; Yue, Zhenyu; Kirik, Deniz; Spillantini, Maria Grazia Journal: Movement disorders Issue: Volume 28:Issue 1(2013) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. Issue 4 (12th February 2016) Authors: Pinna, Annalisa; Ko, Wai Kin D.; Costa, Giulia; Tronci, Elisabetta; Fidalgo, Camino; Simola, Nicola; Li, Qin; Tabrizi, Mojgan Aghazadeh; Bezard, Erwan; Carta, Manolo; Morelli, Micaela Journal: Movement disorders Issue: Volume 31:Issue 4(2016) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease. Issue 6 (7th March 2014) Authors: Ko, Wai Kin D.; Pioli, Elsa; Li, Qin; McGuire, Steve; Dufour, Audrey; Sherer, Todd B.; Bezard, Erwan; Facheris, Maurizio F. Journal: Movement disorders Issue: Volume 29:Issue 6(2014) Page Start: 772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗